Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Biochemical Pharmacology
|
April 22, 2018
A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity
Wentao Pan, Qiuyun Luo, Xianglei Yan, et al.
Antibodies (Basel, Switzerland)
|
April 23, 2024
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
Karsten Beckmann, Carmen Reitinger, Xianglei Yan, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 3, 2018
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma
Hanjie Yi, Xianglei Yan, Qiuyun Luo, et al.
Oncology Research
|
February 26, 2020
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
Qiuyun Luo, Wentao Pan, Suna Zhou, et al.
Molecular Therapy. Methods & Clinical Development
|
October 11, 2022
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
Klara Lenart, Fredrika Hellgren, Sebastian Ols, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 23, 2023
Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
Xianglei Yan, Sebastian Ols, Rodrigo Arcoverde Cerveira, et al.
Cancer Cell International
|
May 24, 2024
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells
Wentao Pan, Qiuyun Luo, Eric Liang, et al.
Oncotarget
|
May 13, 2017
Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
Haibo Chen, Dingyuan Luo, Lin Zhang, et al.
Cell & Bioscience
|
November 2, 2019
Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
Xuechao Liu, Guangfeng Wang, Xianglei Yan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Biochemical Pharmacology
|
April 22, 2018
A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity
Wentao Pan, Qiuyun Luo, Xianglei Yan, et al.
Antibodies (Basel, Switzerland)
|
April 23, 2024
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
Karsten Beckmann, Carmen Reitinger, Xianglei Yan, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 3, 2018
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma
Hanjie Yi, Xianglei Yan, Qiuyun Luo, et al.
Oncology Research
|
February 26, 2020
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
Qiuyun Luo, Wentao Pan, Suna Zhou, et al.
Molecular Therapy. Methods & Clinical Development
|
October 11, 2022
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
Klara Lenart, Fredrika Hellgren, Sebastian Ols, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 23, 2023
Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
Xianglei Yan, Sebastian Ols, Rodrigo Arcoverde Cerveira, et al.
Cancer Cell International
|
May 24, 2024
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells
Wentao Pan, Qiuyun Luo, Eric Liang, et al.
Oncotarget
|
May 13, 2017
Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
Haibo Chen, Dingyuan Luo, Lin Zhang, et al.
Cell & Bioscience
|
November 2, 2019
Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
Xuechao Liu, Guangfeng Wang, Xianglei Yan, et al.
Page
of 2